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Electrospray ionization-tandem mass spectrometry experiments were used to provide evi- 
dence regarding the sites of interactions between zinc metal ions and angiotensin peptides. 
The electrospray ionization mass spectra of hi&dine-containing human angiotensin Il (Asp- 
Arg-Val-Tyr-Ile-His-Pro-Phe) and angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) 
in the presence of zinc show abundant multiply charged ions for the zinc-attached peptide 
[M + uZn2+ +(c - 2u)H+]‘+, where a = 1, 2 and c is charge. From collisionally activated 
dissociation experiments, with both low energy (triple quadrupole mass spectrometry) and 
high energy collisions (linked scan at constant B/E with a double focusing instrument) of the 
[M + Zn12+ and [M + Zn + H13+ ions for angiotensin II, a [be + Zn]*+ species is produced 
as the most abundant product ion, suggesting that the zinc interaction site is in the vicinity of 
the His6 residue. Additionally, tandem mass spectra from the zinc-attached ions for an- 
giotensin 1 show abundant [ b6 + Znl*+ and [b, + Zn]‘+ 
)” 
roducts, providing evidence that 
both His6 and His’ are involved in zinc coordination. J Am Sot Muss Spectrom 1994, 5, 
959-965) 
M eta1 ion binding is an important facet of the function of many protein systems. Metal ions are an integral component of many enzymes 
(metalloenzymes) and are essential to their catalytic 
function and structural stability [l]. Well established 
techniques used to study the interaction between metal 
ions and biological materials include absorption spec- 
troscopy, circular dichroism [2], electron paramagnetic 
resonance spectroscopy [3], nuclear magnetic reso- 
nance (NMR) spectroscopy [3, 41, extended x-ray ab- 
sorption fine structure [5-71, and x-ray crystallography 
[8, 91. A rapidly growing method for investigating 
interactions between metal ions and biomolecules is 
mass spectrometry. 
Many metal binding studies have been reported 
that involve fast-atom bombardment produced singly 
charged metal-peptide complexes and tandem mass 
spectrometry. Information about the intrinsic interac- 
tions of the metal and the peptide have been extracted 
from the dissociation chemistry, based on the assump- 
tion that the charge on the metal ion induces binding 
site-specific fragmentation, and that the high vacuum 
of a mass spectrometer provides an ideal environment 
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to observe intrinsic interactions between peptides and 
metal ions due to the absence of salvation effects. 
Metal ion-peptide interactions that have been studied 
include those that involve alkali [l&17], alkaline earth 
[18-X], and transition metal ions [21, 221. 
Electrospray ionization (&I) [23, 241, which ana- 
lyzes materials from solution, is generating increasing 
interest as a bioanalytical method because it has the 
ability to ionize efficiently large molecular weight 
biomolecules and has the potential to provide primary 
structure information by tandem mass spectrometry 
[25]. The potential of electrospray ionization-mass 
spectrometry (ESI-MS) to determine peptide-metal ion 
stoichiometry in a rapid and sensitive fashion is 
promising. Hutchens and co-workers [26, 271 have 
investigated interactions of CU*+ and Zn*+ to cysteine 
(sulfur) [26, 271 and histidine [28] containing polypep- 
tides with ESI. Their ESI-MS results suggest that ES1 
mass spectra reflect the specific association of the 
metal(s) to the peptide and can,clearly be differenti- 
ated from nonspecific interactions due to clustering or 
adduct formation. Fenselau and co-workers [29] devel- 
oped an ESI-MS strategy that provides analysis of 
metal ions in native and keconstituted metallothionein 
proteins. Seven divalent Zn*+ or Cd*+ metal ions were 
observed to associate with the fully reconstituted pro- 
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tein. This observation agrees well with the results of 
solution studies, and it was therefore suggested that 
metallothionein proteins retain their conformation in 
the gas phase. 
Functionalized side chains of amino acids often de- 
fine the characteristics of peptide interactions with 
metal ions. The imidazole side chain of a histidyl 
residue, in particular, is an excellent electron donor 
and serves as’ a metal binding site in a variety of 
enzymes [l]. Histidine-metal binding also has been 
reported for gas-phase metal-peptide complexes [lo, 
11, 141. The imidazole group involved was either neu- 
tral [30] or deprotonated [21], whereas the peptides 
were all deprotonated species. ln solution, the imida- 
zole side chain of a histidine residue is a good anchor 
for transition metal ions to resist metal hydrolysis and 
induce deprotonation at peptide bonds at high pH [31]. 
In this mass spectrometry study, we target com- 
plexes in which a neutral peptide and Znzt are in- 
volved. Among the first row transition metal ions, 
Zn2’ is the second most abundant and important in 
biological systems [32]. Nearly 300 enzymes in differ- 
ent species of all phyla have zinc as an indispensable 
component for their functions [33, 341. We show the 
impact of histidyl residue(s) on the fragmentation of 
Zn’+-angiotensin peptide complexes and discuss the 
implications to the metal binding site(s) in the peptide. 
Experimental 
EIectrospray Ionization Mass Spectrometer 
Two different instruments and experimental systems 
were utilized for this study. The triple quadrupole 
mass spectrometer (Sciex TAGA 6000E, Thornhill, On- 
tario, Canada; m/z limit 1400) utilizes a modified 
atmospheric pressure inlet that incorporates a differ- 
entially pumped nozzle-skimmer interface [35]. A 
countercurrent stream of nitrogen was used to aid 
droplet desolvation, In addition, control of the voltage 
difference between the nozzle and skimmer elements 
(AV,,) is used to adjust the amount of collisional 
activation the molecules undergo in this region for 
desolvation and at higher levels of AV,,, dissociation 
of the molecule. The ES1 source, which utilizes a liquid 
sheath electrode, has been previously described [35]. 
Methanol or distilled deionized water were used as the 
sheath liquid, with the applied electrospray voltage at 
+4 kV and +5.5 kV, respectively. Sulfur hexafluoride 
(SF,, 99.8% minimum purity) was used as a sheath gas 
and is an effective electron scavenger to suppress 
corona discharge [36], especially at the higher ESI 
voltages necessary for spraying completely aqueous 
solutions. A syringe pump (Harvard Apparatus, South 
Natick, MA) controlled the analyte delivery rate to the 
ES1 source at 0.35 PL min-I. A separate syringe pump 
delivered the sheath liquid flow at a rate of 3 PL 
mti-l. Argon was used as the collision gas for the 
triple quadrupole-tandem mass spectrometry 
experiments. 
ESI-MS analyses also were performed with a Finni- 
gan MAT 900 (Bremen, Germany) forward geometry 
double focusing mass spectrometer [37] equipped with 
a 20-kV conversion dynode-electron multiplier point 
detector and a position and time-resolved ion counting 
array detector (PATRIC). The scanning PATRIC-array 
detector was used for acquisition of most of the data 
from this instrument. Analyses were performed at full 
accelerating potential (5 kV), except for linked scan at 
constant B/E experiments of multiply charged precur- 
sor ions. Sample solutions were infused through the 
ESI source at a flow rate of 0.5-1.5 /.LL mir-‘. Mass 
spectra were typically acquired at 30 s decade-‘. 
The electrospray ionization interface on the double 
focusing instrument is based on a heated glass capil- 
lary inlet [23] (0.5 mm i.d. X 6.2 mm o.d. x 218 mm 
length). In a fashion similar to the ESI-quadrupole 
mass spectrometer interface, droplet desolvation is ac- 
complished by a countercurrent stream of warm n&o- 
gen ( - 60 “C) and by energetic collisions in the electro- 
spray interface. The energy of the collisions is con- 
trolled by the voltage difference between the tube lens 
surrounding the metalized exit of the glass capillary 
and the first skimmer element of the interface (AV,). 
The typical range of AV, used for this work was 
+90-120 V. Sulfur hexafluoride coaxial to the spray 
was also used to suppress corona discharges. 
For linked scan at constant B/E experiments, he- 
lium gas sufficient to reduce the precursor ion abun- 
dance to 50% was introduced into the collision cham- 
ber in the first field-free region. The array detector was 
used for the constant B/E experiments. Due to the use 
of an array detector on a double focusing instrument, 
any precursor ion selectivity of the B/E linked scan 
was lost. The precursor ion beam is actually a sum of 
ions whose masses fall into the 2% window of the 
intended precursor mass. (In practice, the mass-to- 
charge ratio range that is passed tends to be larger 
than 2% of the precursor ion mass-to-charge ratio; 
however, the transmission for ions outside the window 
declines exponentially.) All product ions from all ions 
within the precursor ion window also were recorded. 
This inherent lack of precursor ion selectivity some- 
times causes artifacts in the tandem mass spectrum if 
there are any other potential precursor ions (including 
precursors that contain heavy isotopes) whose masses 
fall in this mass window. Because of the relatively low 
resolution in precursor selectivity, the entire isotopic 
distribution of the precursor ion is passed (as opposed 
to only the 12C isotope ion) and is reflected in the 
product ion isotopic distribution pattern. Product ion 
resolution is generally greater than 1000. 
Materials 
Angiotensin I, angiotensin II, N-acetyl-renin substrate 
tetradecapeptide, and substance P were purchased 
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from Sigma Chemical (St. Louis, MO) and were used 
without further purification. I’eptide AAAYAA was 
purchased from Bachem Bioscience (Philadelphia, PA). 
Peptides with the sequence DRVYIAPF ([Ala6]-angio- 
tensin II) and DRVYIHAF ([Ala7]-angiotensin II) were 
provided by Dr. Wayne Cody (Parke-Davis Pharma- 
ceutical Research, Arm Arbor, MI). For the triple 
quadrupole mass spectrometry studies, peptide solu- 
tions, at concentrations approximately 100 pm01 I*L-‘, 
were prepared in distilled deionized water with either 
5% glacial acetic acid (v/v> or no acetic acid added 
(see Results and Discussion). For experiments that 
used the double focusing mass spectrometer, samples 
were prepared at a concentration of lo-50 pmol yL_’ 
in distilled water with acetic acid or ammonium hy- 
droxide added to adjust the pH. 
Results and Discussion 
Gas-Phase Zn2+-Angiotensin Peptide Complexes 
The addition of 1-lo-mM ZnCl, to a pH 6, 50-100 
pm01 pL_’ aqueous solution of angiotensin II (M, = 
1046, DRVYIHPF) yielded electrospray mass spectra 
that showed the incorporation of one Zn’+ ion bound 
to the peptide, with a much less abundant set of peaks 
that represented two zinc ions bound to the peptide 
(Figure la). Angiotensin I (M, = 1296, DRVYIHPFHL) 
has histidine residues at positions 6 and 9. The ES1 
mass spectrum of human angiotensin I in the presence 
of l-n&i ZnCl, again shows the association of one zinc 
ion as the most abundant species (Figure lb). From 
accurate mass measurements taken from higher resolu- 
tion scanning experiments with the double focusing 
instrument ( - l-ppm mass accuracy), the general for- 
mula that describes the stoichiometry of the complex is 
given by [M + aZn2++(c - 2a)H+lC+, where c is 
charge. The relative abundance of the peptide-metal 
complex plateaus near pH 6-7 and falls off dramati- 
cally at pH 3 and 10. 
The relative abundance of the metal-bound ions is 
dependent on charge state. As shown in Figure la and 
b, the relative abundance uf the [M + Zn + (c - 
2)H]‘+ ions versus [M t cHIC+ ions increases with 
increasing charge c. (The same trend is observed for 
the relative abundance of the [M + 2Zn + (c - 4)H]‘+ 
ions.) The isotopic abundance ratio of zinc for masses 
64:66:67:68:70 is 100:57.4:8.4:38.7:1.3. This isotopic pat- 
tern is an unique fingerprint for any ionic species that 
incorporates zinc, as shown by the collisionally acti- 
vated dissociation (CAD) data. 
Collisionally Activated Dissociation of 
Zn2 +-Angiotensin Peptide Complexes 
Comparison of the CAD mass spectra of the proton- 
ated and metal-bound peptides provides information 
regarding the nature of the metal-peptide interaction. 
CAD of the [M + 2H]*+ molecule for angiotensin II 
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Figure 1. Electrospray ionization quadrupole rna~~ spectra of 
(a) human angiotensin II and (b) angiotensin I in the presence of 
1-mM ZnC12. S mbols are used to label some of the peaks: A, 
[M ~ H + 2Zn&; 0, [M + 2H + Z#+; +, [M + 2Zn]‘+. The 
inset of (a) shows an expansion of the [M + Z#+ region of the 
spectrum acquired with the double focusing instrument at a 
resolution of 8000. 
shows a series of a,/b,, singly charged product ions 
under both low energy collision conditions (triple 
quadrupole) and higher energy collisions (EB) (Figure 
2a and 3a, respectively). CAD of the [M + Zn]‘+ 
molecule, obtained with both instrumental systems, 
produces primarily the [ b6 + Znf’/[ a6 + Zn]‘+ pair 
in addition to the ions formed by water loss (ap- 
proximately 30% relative abundance; see Figures 2b 
and 3b). [Nomenclature used for the oligopeptide frag- 
mentation pattern is based on conventional notation 
[38]. A superscript is added to indicate the fragment 
ion charge state. For dissociation of the Zn-peptide ion 
complex, Zn-&ached product ions are explicitly la- 
beled as the zinc-containing species (e.g., [b, + Zn]‘+). 
An ion not explicitly labeled with zinc (e.g., b:) should 
be assumed to be not zinc bound.] This kind of spec- 
tral simplification that occurs upon metal ion complex- 
ation was pointed out by Cross and co-workers [14] for 
alkali metal ions. Dissociation of the His’-Pro7 bond 
is seemingly favored upon association with zinc. 
Zinc binding has a similar influence on the CAD of 
angiotensin I. The CAD mass spectra of the doubly 
(Figure 4a) and triply (Figure 5a) proton&d species 
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Figure 2 ESICAD mass spectra of the (a) [M + 2H]*+ and 
(b) [M + Zn12+ molecules of angiotensin II, acquired with the 
Figure 4. ESI-linked scan at constant B/E of the (a) [M + 2H]” 
triple quadrupole mass spectrometer (argon collision gas). 
and (b) [M + Zt#+ molecules of angiotensin I, acquired with 
the double focusing mass spectrometer (helium collision gas). 
i 
2Do 
Figure 3. Linked scan at constant B/E of the (a) [M + 2Hl” Figure 5. CAD spectra (triple quadrupole mass spectrometer) of 
and (b) [M + Znl’+ molecules of angiotensin II (helium collision the (a) [M + 3H]‘+ and (b) [M + H + Zn]‘+ species of an- 
gad. giotensin I. 
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from angiotensin I show singly and doubly charged 
fragments distributed across the entire backbone. CAD 
of the [M + Zn]‘+ at m/z 681 yields an ion at m/z 
615, which represents the zinc-attached lb, + Znl*’ 
species, as the most abundant product ion, with smaller 
contributions from [b, + Zn12+ (Figure 4b). Dissocia- 
tion of the His’-Leu” amide bond is favored over 
dissociation of the His6-Pro’ bond for the 
zincpangiotensin I complex (vi& infua). The CAD spec- 
trum for the [M + Zn + H13’ parent ion (Figure 5b) 
also shows the [b, + Zr#‘/[ ug + Zn]‘+ pair as the 
dominant peaks with lower abundance peaks for bi+ 
and [b, + Zn]*+ also evident. Similar CAD data were 
obtained from goosefish angiotensin I (n/l, = 1282), 
where Asp’ and Ile5 of human angiotensin I have been 
replaced with Asn and Val, respectively. An ion that 
corresponds to a zinc-containing ys product ion from 
dissociation of Arg*- Va13 also was observed (Figure 
4b). A similar fragmentation product also was ob- 
served for the angiotensin II-zinc complex (i.e., [ y6 - 
2H + Zn]+; Figure 3b). 
Zinc-Histidins Binding 
Metal cationization by Zn” was observed to dramati- 
cally reduce the number of CAD fragmentation chan- 
nels for the angiotensin peptides (e.g., compare the 
fragmentation of [M + 2H]*+ with that of [M + Zn]‘+). 
The major product ions (except water loss) are formed 
by reactions at the histidine sites (His6-Pro for an- 
giotensin II; Hi@-Pro and His’-Leu for an- 
giotensin I). This histidine specificity may be the result 
of preferential binding of Zn2+ to the histidine residue 
and the charge on the metal ion induces fragmentation 
at that site. This is further supported by the experi- 
mental results with [Ala6]-angiotensin II and other 
non-histidine-containing peptides such as substance P. 
The Ala’--Pro bond is only one fragmentation site 
among others in the CAD spectrum of the ([Ala6]- 
angiotensin II + Z# + complex (Figure 6), and the ion 
due to water loss becomes the most abundant product 
ion. CAD of ([Ala6]-angiotensin II +2HlZf, however, 
gives abundant bl and bi+ ions, in agreement with 
previous studies on the influences of proline over the 
fragmentation of protonated peptides 1391. Substance P 
(RPKPQQFFGLM-NH,) does not contain histidine as 
well. The major fragmentation channels for [substance 
P + Zn]*+ are the same for [substance P + ZH]‘+. The 
protonated species produces both singly and doubly 
charged a7, ua, b,, ulu, and b,, ions 1401, whereas the 
Zn2+ complex produces Zn2+-attached product ions of 
the same type (e.g., [b,, + Zn - HI+). Also, the frag- 
mentation efficiency is reduced dramatically for the 
Zn2+ complex for non-histidine-containing peptides 
(see Figure 6). This lends further support to the notion 
that the facile fragmentation at the hi&dine sites is 
promoted by Zn2+ attachment to histidine residues. 
Dissociation of the amide X-Pro bond has been 
observed to be a favored process for multiply charged 
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Figure 6. ES&CAD (B/E linked scan) mass spectra of the 
(a) [M + 2H12+ and (b) [M + 2111~~ molecules of the non-histi- 
dine-containing peptide DRVYIAPF CM, = 979.5). 
ions under CAD conditions [39], but Loo et al. [39] 
have provided evidence from low energy CAD experi- 
ments that the process may not be as favorable when X 
is a positively charged basic residue (i.e., Arg, Lys, 
His). It is unlikely that proline plays a major role in the 
formation of the [b, + Zn12+ product ion for zinc-con- 
taining angiotensin peptides. The CAD spectrum for 
([Ala71 - angiotensin II + Zn)‘+ (where Pro7 has been 
replaced by alanine) is virtually the same as the 
[angiotensin II + Zn]‘+ complex (see Figures 2b and 
3b); the [b, + Zn12+ product is the dominant fragment 
species. 
The only other significant CAD fragmentation of 
Zn*+-angiotensin peptide complexes is the loss of wa- 
ter. The relative abundance of the water loss product is 
about 30% for the angiotensin II-zinc complex, 
whereas the ion due to water loss is the most abundant 
fragment for the angiotensin I and [Ala6]-angiotensin 
II complexes. The N-terminal aspartic acid is appar- 
ently the site for water loss to occur because no water 
loss was observed from zinc-peptide complexes that 
do not contain aspartic acid (e.g., substance l’). The 
C-terminal site is eliminated as a possible zinc binding 
site because the CAD spectrum of [AAAYAA + Zn12+ 
showed no significantly abundant [M - Ha0 + Zn]” 
ion. CAD of the [M + 2H]‘+ angiotensin peptide 
molecule did not yield a product from the loss of 
water; thus the reaction of elimination of a water 
molecule appears to be promoted by metal binding. 
This leads to the possibility of metal binding to the 
N-terminal residue. Supporting evidence is provided 
from the observed enhancement of the formation of the 
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[M - H,O + Zn] ‘* ion (Figure 6) from the [M + 
Zx$+ complex of [Ala6]-angiotensin II compared with 
the zinc-angiotensin II complex (Figures 2b and 3b). 
The replacement of histidine by alanine at position 6 of 
angiotensin II eliminated the “preferred” Znzf-binding 
site, and the N-terminal residue becomes the most 
favored Zn’+ site. The apparent increase in metal 
binding to the N-terminus results in a more abundant 
water loss ion in the CAD spectrum. However, the loss 
of water is also the most facile process in the CAD of 
the Zn2+ complex of N-acetyl-renin substrate tetrade- 
capeptide (AC-DRVYIHPFHLVIHN). Because the N- 
terminus is no longer a primary amino group, the 
abundant water loss only suggests that aspartic acid 
itself is a favorable Zn*+ binding site. Therefore, the 
N-terminal Zn2+ binding revealed by our CAD data 
could be a result of the intrinsic affinity of Zn*+ 
toward the aspartic acid residue, Which also was re- 
ported to be a good Zn** ligand [34]. The question 
regarding the intrinsic affinity of aspartic acid is be- 
yond the scope of this paper and is to be addressed in 
a later study. Thus, the N-terminus also appears to 
participate in zinc binding, contributing to the struc- 
ture composite of Zr?-angiotensin peptide com- 
plexes, although the population of the complexes that 
have such metal binding appears to be small. 
To explain the tandem mass spectrometry experi- 
mental observations, a structure that presents strong 
metal binding and at the same time facilitates the 
fragmentation pathways in the CAD is necessary. His- 
tidine is the most frequently found metal-binding lig- 
and in Znzf sites of enzymes 1341. It coordinates to 
metal ions by its imidazole ring nitrogen(s). In the 
postulated structure 1, Zn2+ is coordinated to one of 
the imidazole nitrogens and two immediate carbonyl 
oxygens. The metal binding in this structure imparts 
minimum constraints on the peptide. Only histidine 
and the preceding carbonyl group are subjected to 
constraints. From an entropy loss -point of view this 
structure has obvious advantages over metal binding 
to other amino acids or to the N-terminal amine group 
because a tridentate metal binding requires folding a 
much larger portion of the peptide. Formation of b-type 
ions at the hi&dine site from this structure is feasible 
and the charge on the immediately neighboring metal 
ion should be effective in activating the bonds. 
Bidentate coordination of Zn*+ by the two histidine 
residues of angiotensin I is also possible, as suggested 
by NMR studies [41]. The weakly formed as+/bz+ 
pair (compared with a;+/b$“) from the angiotensin I 
[M + Zn]‘+ complex may point to bidentate coordina- 
tion because such a structure should promote the for- 
mation of ag+/b;+ and inhibit the formation of the 
az’/b,f’ product ion pair. The weak formation of 
ai+/bi’ may be the result of a composite of structures 
(i.e., some fraction of the population of the complex 
may have a monodentate structure). Further evidence 
also can be found in the ES1 mass spectra (Figure 1). 
The relative ratio of the ions that have two zinc metal 
ions attached to the peptide ([M + 2Zn]4’) to the ions 
with one zinc attachment ([M + Zn12+ 1 are similar for 
angiotensin I and angiotensin II. The additional histi- 
dine residue in aneiotensin I does not increase the 
” 
relative abundance of the ions that contain two zinc 
ions. Apparently, the two histidine residues in an- 
giotensin I do not harbor metal ions separately. 
Metal ions such as Ni2+ and Cu2+ have been shown 
to bind to human angiotensin II (DRVYIHPF) in the 
vicinity of the imidazole nitrogen of the histidine side 
chain [42, 431. A recent ‘H NMR study provided 
evidence for Zn*+ coordination to the imidazole rings 
of both hi&dine residues of human angiotensin I [41]. 
The binding sites of copper and palladium to an- 
giotensin I and II were also assessed by using cali- 
fomium-252 plasma desorption (252Cf-PD) mass spec- 
trometry [44, 451. From the fragment ions observed in 
the PD mass spectra of peptide samples that contain 
metal ions, it was concluded that the NHrterminal 
amino group as well as the histidine imidazole ring are 
the metal-binding sites; the NH,-terminal amino group 
has a stronger affinity for Cu(II) and I’d011 [44, 451. 
Our ES1 tandem mass spectrometry data support the 
histidine site as the most favored region for zinc bind- 
ing. ES1 tandem mass spectrometry experiments with 
copper and palladium will be needed to clarify the 
discrepancies in the data from the two methods. Tan- 
dem mass spectrometry is more likely a less ambigu- 
ous method for distinguishing between specific and 
nonspecific interactions. 
Conclusions 
Electrospray ionization combined with tandem mass 
spectrometry has allowed the study of interactions 
between neutral peptides (no deprotonation of an 
amide group) and metal ions. Interactions of this na- 
ture in the gas phase are usually not amenable to 
investigations by other mass spectrometry ionization 
techniques (e.g., fast-atom bombardment). The dissoci- 
ation of these gas-phase complexes occurs nearly ex- 
clusively at the histidine site(s), which suggests that 
Zn2+ binds angiotensin peptides in’the vicinity of the 
histidine residues in either a monodentate or bidentate 
structure. Zn2’ binding to the N-terminus also may 
contribute to the structure composite, but the affinity 
of the N-terminal amino group appears to be lower 
than the histidine residue. 
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